Phase 3 TRIUMPH topline figures (often cited around the high-20% range at 6880 weeks) are company-reported and, at the time of writing, are not the peer-reviewed Phase 2 dataset cited above
Sergey Terushkin, MD, FACS , a board-certified surgeon with experience in bariatric care, metabolic health, and physician-guided weight management
No matter how much exercise or restrictive diet I would put myself through the weight would never leave my gut
Novel unimolecular tetra-agonist peptides targeting GLP-1, GIP, amylin, and calcitonin receptors with enhanced metabolic benefits in animal models of obesity
But all that aside, the important thing to acknowledge is how incredibly difficult it can be for people with obesity to lose that weight and how few safe options doctors have had to help them, which is why it was such a big deal when these hit the market